Pandemics- One Health preparedness for the next.
Journal
The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
ppublish
Résumé
The majority of emerging infectious diseases originate in animals. Current routine surveillance is focused on known diseases and clinical syndromes, but the increasing likelihood of emerging disease outbreaks shows the critical importance of early detection of unusual illness or circulation of pathogens - prior to human disease manifestation. In this Viewpoint, we focus on one key pillar of preparedness-the need for early warning surveillance at the human, animal, environmental interface. The COVID-19 pandemic has revolutionized the scale of sequencing of pathogen genomes, and the current investments in global genomic surveillance offer great potential for a novel, truly integrated Disease X (with epidemic or pandemic potential) surveillance arm provided we do not make the mistake of developing them solely for the case at hand. Generic tools include metagenomic sequencing as a catch-all technique, rather than detection and sequencing protocols focusing on what we know. Developing agnostic or more targeted metagenomic sequencing to assess unusual disease in humans and animals, combined with random sampling of environmental samples capturing pathogen circulation is technically challenging, but could provide a true early warning system. Rather than rebuilding and reinforcing the pre-existing silo's, a real step forward would be to take the lessons learned and bring in novel essential partnerships in a One Health approach to preparedness.
Identifiants
pubmed: 34642673
doi: 10.1016/j.lanepe.2021.100210
pii: S2666-7762(21)00187-3
pmc: PMC8495373
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100210Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
Funding to the institution. No involvement in the writing. None other to declare.
Références
Vaccine. 2019 Nov 15;37(48):7190-7200
pubmed: 28890191
Lancet Infect Dis. 2018 May;18(5):545-553
pubmed: 29396001
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
Euro Surveill. 2019 Mar;24(10):
pubmed: 30862334
Nature. 2021 Feb;590(7845):195-196
pubmed: 33542487
Sci Rep. 2020 Aug 13;10(1):13748
pubmed: 32792677
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20814-20825
pubmed: 32769208
Euro Surveill. 2017 Nov;22(45):
pubmed: 29162204
Prev Vet Med. 2011 Sep 1;101(3-4):148-56
pubmed: 20832879
Emerg Infect Dis. 2012 Mar;18(3):469-72
pubmed: 22376991
Nature. 2021 May;593(7858):176-177
pubmed: 33953391
Viruses. 2021 Apr 08;13(4):
pubmed: 33917745
Nature. 2019 Nov;575(7781):130-136
pubmed: 31695207
Science. 2018 Oct 26;362(6413):404-406
pubmed: 30361362
Nucleic Acids Res. 2021 Jan 8;49(D1):D82-D85
pubmed: 33175160
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Sci Rep. 2015 Jul 10;5:11444
pubmed: 26161690
Prev Vet Med. 2020 Aug;181:104560
pubmed: 30528937
Methods Mol Biol. 2019;1918:201-212
pubmed: 30580411
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Nat Genet. 2016 Jul 27;48(8):821
pubmed: 27463394
Euro Surveill. 2021 Mar;26(9):
pubmed: 33663647
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500
pubmed: 32780112
Nat Commun. 2019 Mar 8;10(1):1124
pubmed: 30850636
Rev Sci Tech. 2017 Aug;36(2):435-444
pubmed: 30152473
Cell. 2021 Jun 24;184(13):3376-3393.e17
pubmed: 34043940
Int J Equity Health. 2021 Jan 9;20(1):28
pubmed: 33422065
J Microbiol Methods. 2014 Sep;104:1-8
pubmed: 24918990
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508